BUSINESS
    Mitsubishi Tanabe Staffers Tapping New Support System to Balance Work and Infertility, Medical Treatment
    January 18, 2019
    More and more employees of Mitsubishi Tanabe Pharma are taking advantage of the company’s support system to balance work and medical care introduced last October, with several already applying for its use for infertility treatments,…

    LATEST

    Concomitant Insulin a Must for Suglat Use in Type 1 Diabetes: Specialist
    January 18, 2019
    It is important to always use insulin when Astellas Pharma’s SGLT2 inhibitor Suglat (ipragliflozin), which was approved for an additional indication of type 1 diabetes late last month, is given to type 1 diabetes patients,…
    Iron Deficiency Med Ferinject Up for MHLW Panel Review on Jan. 31; No Vyvanse Discussion This Time
    January 18, 2019
    The health ministry’s de-facto decision-making body for drug approval will review Zeria Pharmaceutical’s iron deficiency treatment ferric carboxymaltose on January 31, but is skipping discussions on Shionogi’s ADHD drug lisdexamfetamine dimesylate, which was put on hold at the last meeting…
    Ethical Drug Sales Slip 0.2% in November: Crecon
    January 18, 2019
    Japan’s ethical drug sales inched down 0.2% in November versus the same month the previous year on a wholesaler shipment basis, according to a flash report released by Crecon Research & Consulting. The reporting month had one more business day…

    COMMENTARY

    2019 Likely to Herald Burst of “Regenerative Medicine” Approvals
    By Shinya Sato

    As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

    Takeda’s £46 Billion Shire Buyout

    Takeda Completes £46 Billion Shire Acquisition

    Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

    COLUMN

    Expat Truths from the Japanese Medical Device World
    By Gregory Ng

    To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

    TRENDS

    Generic Industry at Crossroads: Companies Face Pressing Need to Boost Profitability ahead of FY2020
    By Reiji Anasako

    While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

    NEWS CATEGORY

    REGULATORY

    BUSINESS

    ORGANIZATION

    ACADEMIA